ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,474,000 | -31.5% | 75,000 | 0.0% | 0.43% | -26.3% |
| Q2 2018 | $2,152,000 | +82.1% | 75,000 | +50.0% | 0.58% | +77.1% |
| Q1 2018 | $1,182,000 | -38.2% | 50,000 | -33.3% | 0.33% | +12.0% |
| Q2 2016 | $1,913,000 | -71.1% | 75,000 | -70.0% | 0.29% | -66.6% |
| Q1 2016 | $6,613,000 | +54.6% | 250,000 | +150.0% | 0.88% | +44.2% |
| Q4 2015 | $4,278,000 | +193.4% | 100,000 | +81.8% | 0.61% | +228.1% |
| Q3 2015 | $1,458,000 | -67.8% | 55,000 | -59.6% | 0.18% | -64.7% |
| Q2 2015 | $4,533,000 | -35.1% | 136,000 | -35.2% | 0.52% | -28.5% |
| Q1 2015 | $6,989,000 | – | 210,000 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 1,526,174 | $1,423,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 250,271 | $233,000 | 0.06% |
| Spark Investment Management LLC | 110,300 | $102,000 | 0.05% |
| SALZHAUER MICHAEL | 30,000 | $28,000 | 0.05% |
| HAP Trading, LLC | 260,800 | $532,000 | 0.04% |
| Point72 Asset Management, L.P. | 1,589,600 | $1,482,000 | 0.01% |
| DLD Asset Management, LP | 208,400 | $196,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,893,678 | $1,765,000 | 0.01% |
| EVERENCE CAPITAL MANAGEMENT INC | 65,680 | $61,000 | 0.01% |
| Benin Management CORP | 11,714 | $11,000 | 0.01% |